Unaffordable insulin: patients pay the price.

Lancet Diabetes Endocrinol

T1International, 6 Little Pheasants, Cheltenham GL53 8EJ, UK.

Published: October 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(19)30260-8DOI Listing

Publication Analysis

Top Keywords

unaffordable insulin
4
insulin patients
4
patients pay
4
pay price
4
unaffordable
1
patients
1
pay
1
price
1

Similar Publications

Objectives: This study aims to assess access to essential medicines used in the management of noncommunicable diseases through analysis of the availability, prices, and affordability of these essential medicines in Arba Minch town, Gamo Zone, Southern Ethiopia.

Methods: A cross-sectional design was carried out using the World Health Organization/health action international methodology between 2 March and 2 May 2023, within public and private healthcare facilities located in Arba Minch town, Southern Ethiopia. The median price ratio served as a metric.

View Article and Find Full Text PDF

Background: In South Africa (SA), most patients rely on the government for free healthcare. Some choose to subscribe to a medical insurance scheme. If insulin is unavailable in government or otherwise unaffordable, non-adherence may occur, which can increase complications of the disease.

View Article and Find Full Text PDF

The alarming state of global insulin access in low-resource settings presents a major barrier to diabetes care. A comprehensive review of these challenges is lacking at the global level. To address this weakness, enhance affordability and build capacity for a more sustainable approach to scaling up access.

View Article and Find Full Text PDF

Background: The prevalence of diabetic foot ulcers, a common, more serious chronic diabetes-related complication, is increasing. Vacuum sealing drainage (VSD) constitutes an effective adjunctive treatment for diabetic foot ulcers. Factors, such as poor glycemic control, ischemia, and infection prolong wound healing time, and VSD products are expensive and unaffordable for many patients.

View Article and Find Full Text PDF
Article Synopsis
  • Diabetes Mellitus is a growing global health crisis, impacting over 500 million people with an alarming increase in cases among those under 20 and high mortality rates, while insulin accessibility remains a significant issue worldwide.
  • Researchers developed a method for oral delivery of engineered proinsulin using plant cells, achieving stable expression and meeting FDA standards, thus potentially making treatment more accessible and cost-effective.
  • The study demonstrated that oral proinsulin effectively regulates blood sugar levels in mice similarly to natural insulin, presenting a viable alternative to traditional insulin injections and paving the way for potential clinical applications.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!